Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2026-01-04 @ 2:00 PM
Study NCT ID:
NCT03347292
Status:
COMPLETED
Last Update Posted:
2023-07-25
First Post:
2017-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
Sponsor:
Organization: